Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026)

Updated

Dr Reddys Laboratories' Operating Margin was 4.69% in the quarter ended Jun 30, 2026, down 15.76 percentage points from 20.45% a year earlier and down 32.04 percentage points from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Dr Reddys Laboratories' Operating Margin was 22.02% through Jun 30, 2026, up 5.77 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 15.06%, down 7.01 percentage points from the prior year.

  • Operating Margin shows a five-year change of +2.26 percentage points (years ended Mar 2021 to Mar 2026).
  • In earlier years, Operating Margin was 22.07% in the year ended Mar 31, 2025 (-2.20 pp), 24.27% in the year ended Mar 31, 2024 (+1.04 pp), 23.23% in the year ended Mar 31, 2023 (+9.46 pp) and 13.77% in the year ended Mar 31, 2022 (+0.97 pp).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Operating Margin since the quarter ended Mar 31, 2025.
  • Compared with a year earlier, Operating Margin was higher in three of the last eight quarters, with an average year-over-year change of +4.77 percentage points.
  • The best year-over-year quarter for Operating Margin over five years was the quarter ended Mar 31, 2026 (a gain of 36.47 percentage points); the worst was the quarter ended Mar 31, 2024 (a drop of 25.71 percentage points).
  • Per Business Quant data, RDY's Operating Margin in the three quarters before the quarter ended Jun 30, 2026 was 36.73% (quarter ended Mar 31, 2026), 26.94% (quarter ended Dec 31, 2025) and 19.89% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 4.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.69%
Mar 31, 2026 36.73%
Dec 31, 2025 26.94%
Sep 30, 2025 19.89%
Jun 30, 2025 20.45%
Mar 31, 2025 0.26%
Dec 31, 2024 22.40%
Sep 30, 2024 21.89%
Jun 30, 2024 23.36%
Mar 31, 2024 0.43%
Dec 31, 2023 0.30%
Sep 30, 2023 25.97%
Jun 30, 2023 25.97%
Mar 31, 2023 26.14%
Dec 31, 2022 19.69%
Sep 30, 2022 24.27%
Jun 30, 2022 23.42%
Mar 31, 2022 2.79%
Dec 31, 2021 10.46%
Sep 30, 2021 17.40%
API Access

Dr Reddys Laboratories Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY